INSM

Q: What is the price of Insmed (INSM) today?

The price of Insmed (INSM) today is $ 209.02, with return of 182.12% compared to the last year. The price of Insmed (INSM) started the year trading around $ 69.04 and today it is at $ 209.02. Follow the real-time price chart, the historical price of Insmed (INSM) and international markets.

Q: When does Insmed (INSM) pay dividends?

Insmed (INSM) did not distribute dividends in the last year.

Q: Is Insmed (INSM) worth it?

Currently, Insmed (INSM) is priced at $ 209.02, with a P/E of -35.59%, representando um desvio de -1,353% em relação ao seu P/L médio histórico. No último ano, a ação apresentou a variation of 182.12 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 182.12%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Insmed (INSM) stock?

Investing in stocks of Insmed (INSM) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Insmed (INSM) yield today?

The yield of Insmed (INSM) was 30.92% in the last month, 182.12% in the last year and 425.18% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of Insmed (INSM) today, the total investment would be $ 20,902.00, based on the current price of $ 209.02.If past performance were to repeat, the return on your investment would be:In 1 year: $ 58,968.72In 5 years: $ 109,773.12In 10 years: $ 267,869.58It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Insmed Incorporated

Price

$ 209.02

return (12m)

182.12%

p/e

-35.59

p/bv

44.56

DIVIDEND YIELD

0.00%

price INSM

INSM

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return of INSM

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

30.92%

3 months

55.37%

1 year

182.12%

2 years

773.10%

5 years

425.18%

10 years

1,181.55%

Fundamentals INSM

review the fundamentals of Insmed shares

P/E

-35.59

Sector: -3.40 Industry: -3.40

P/SALES RATIO (PSR)

94.26

Sector: -3.36 Industry: -3.36

P/BV

44.56

Sector: 1.98 Industry: 1.98

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-50.15%

Sector: -62.78% Industry: -62.78%

ROE

-125.20%

Sector: -68.26% Industry: -68.26%

ROIC

-195.52%

Sector: -1,140.39% Industry: -1,140.39%

NET MARGIN

-100.00%

Sector: -41.80% Industry: -41.80%

GROSS MARGIN

76.54%

Sector: 39.33% Industry: 39.33%

OPERATING MARGIN

-100.00%

Sector: -41.58% Industry: -41.58%

P/EBITDA

-38.75

Sector: -3.48 Industry: -3.48

P/EBIT

-38.27

Sector: -3.60 Industry: -3.60

P/ASSET

17.85

Sector: 1.42 Industry: 1.42

BVPS

4.46

Sector: 1.79 Industry: 1.79

EPS

-5.58

Sector: -2.05 Industry: -2.05

EQUITY RATIO

0.40

Sector: 0.42 Industry: 0.42

CAGR REVENUE 5 YEARS

22.15%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

32.12%

Sector: - Industry: -

Fundamentals INSM

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	19.42	0.00	0.00%	2.51%	$ 487.73 B	27.26%
PFE	14.23	1.50	10.56%	6.95%	$ 139.89 B	15.65%
ABBV	102.44	-2,793.44	-2,726.81%	2.97%	$ 385.49 B	6.45%
NVO	13.73	7.92	57.70%	3.54%	$ 211.67 B	32.78%
MRK	12.83	0.00	0.00%	3.31%	$ 244.20 B	29.63%
AZN	30.03	6.14	20.45%	1.72%	$ 282.28 B	16.17%
BMY	15.59	5.06	32.47%	5.36%	$ 94.17 B	12.57%
GILD	19.41	7.34	37.80%	2.48%	$ 157.41 B	27.88%
ZTS	20.40	10.02	49.11%	1.58%	$ 54.07 B	28.21%
HALO	13.82	16.33	118.17%	0.00%	$ 8.23 B	47.91%
REGN	17.17	2.54	14.79%	0.35%	$ 78.61 B	32.13%
AMGN	25.92	18.88	72.82%	2.78%	$ 181.60 B	19.47%
VRTX	29.73	6.31	21.22%	0.00%	$ 109.25 B	31.35%
MCK	26.63	-185.79	-697.75%	0.34%	$ 107.39 B	1.04%
ADMA	19.60	9.52	48.57%	0.00%	$ 4.11 B	42.87%
CAH	31.26	-18.26	-58.40%	0.97%	$ 49.86 B	0.68%
BIIB	16.02	1.42	8.83%	0.00%	$ 25.77 B	15.98%

Stock vs Index Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

INSM Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT THE COMPANY Insmed

Insmed Incorporated

Average user rating I10

4.0 (4 people)

United States

26 years

Founded: 1999

2000

Time since IPO - 25 years

521

Employees

The Company Insmed Incorporated (United States), is listed on Nasdaq with a market cap of $ 42.14 Billions, having an equity of $ 945.57 Millions.

With a total of 521 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ 447.02 Millions, which generated a loss in the amount of $ -1.18 Billion.

As for its main indicators, the Company has a P/E ratio of -35.59, a P/BV ratio of 44.56 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker INSM.

Market cap

$ 42.14 Billions

Equity

$ 945.57 Millions

US$ 945,570,000.00

Assets

$ 2.36 Billions

US$ 2,360,740,000.00

Total Shares Outstanding

212.00 Millions

212,000,000

Average Daily Trading Volume

$ 2.16 Millions

US$ 2,163,748.00

Sector

Health Care

Industry

Biotechnology

INSM

INSM revenue and profits

Financial Results INSM

DRAG THE FRAME TO SEE MORE DATA

INSM cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 889.28 43,05% (12M)

P/E

26.63

0.34%

ROE

-697.75%

P/BV

-185.79

CAH - Cardinal Health

$ 213.73 77,50% (12M)

P/E

31.26

0.97%

ROE

-58.40%

P/BV

-18.26

JNJ - Johnson & Johnson

$ 206.67 39,00% (12M)

P/E

19.42

2.51%

ROE

0.00%

P/BV

0.00

MRK - Merck & Co.

$ 105.66 8,77% (12M)

P/E

12.83

3.31%

ROE

0.00%

P/BV

0.00

PFE - Pfizer

$ 25.72 8,48% (12M)

P/E

14.23

6.95%

ROE

10.56%

P/BV

1.50

ABBV - AbbVie

$ 231.80 32,43% (12M)

P/E

102.44

2.97%

ROE

-2,726.81%

P/BV

-2,793.44

AZN - AstraZeneca

$ 93.24 43,50% (12M)

P/E

30.03

1.72%

ROE

20.45%

P/BV

6.14

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 889.28 43,05% (12 M)

P/L

26.63

0.34%

ROE

-697.75%

P/VP

-185.79

CAH - Cardinal Health

$ 213.73 77,50% (12 M)

P/L

31.26

0.97%

ROE

-58.40%

P/VP

-18.26

JNJ - Johnson & Johnson

$ 206.67 39,00% (12 M)

P/L

19.42

2.51%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 105.66 8,77% (12 M)

P/L

12.83

3.31%

ROE

0.00%

P/VP

0.00

PFE - Pfizer

$ 25.72 8,48% (12 M)

P/L

14.23

6.95%

ROE

10.56%

P/VP

1.50

ABBV - AbbVie

$ 231.80 32,43% (12 M)

P/L

102.44

2.97%

ROE

-2,726.81%

P/VP

-2,793.44

AZN - AstraZeneca

$ 93.24 43,50% (12 M)

P/L

30.03

1.72%

ROE

20.45%

P/VP

6.14

Frequently Asked Questions

What is the price of Insmed (INSM) today?

The price of Insmed (INSM) today is $ 209.02, with return of 182.12% compared to the last year. The price of Insmed (INSM) started the year trading around $ 69.04 and today it is at $ 209.02. Follow the real-time price chart, the historical price of Insmed (INSM) and international markets.

When does Insmed (INSM) pay dividends?

Insmed (INSM) did not distribute dividends in the last year.

Is Insmed (INSM) worth it?

Currently, Insmed (INSM) is priced at $ 209.02, with a P/E of -35.59%, representando um desvio de -1,353% em relação ao seu P/L médio histórico. No último ano, a ação apresentou a variation of 182.12 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 182.12%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy Insmed (INSM) stock?

Investing in stocks of Insmed (INSM) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of Insmed (INSM) yield today?

The yield of Insmed (INSM) was 30.92% in the last month, 182.12% in the last year and 425.18% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 0.00 in dividends, a Dividend Yield of 0.00%.

If you wanted to buy 100 stocks of Insmed (INSM) today, the total investment would be $ 20,902.00, based on the current price of $ 209.02.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 58,968.72
In 5 years: $ 109,773.12
In 10 years: $ 267,869.58

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

INSM

Insmed Incorporated

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return of INSM

review the fundamentals of Insmed shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY RATIO

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 0.00%

ABOUT THE COMPANY Insmed

Insmed Incorporated

United States

26 years

2000

521

PROFIT X PRICE INSM

Financial Results INSM

INSM cash flow

asset growth - INSM

INSM balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

ABBV - AbbVie

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

ABBV - AbbVie

AZN - AstraZeneca

Frequently Asked Questions